FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds, Realm US, Authority Hl7

19,367 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

 

Start Prev Rows 11800 - 12000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateUsage #
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.297.jsonSolid cancer M Stage (metastatic)active2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.298.jsonSolid Cancer T Stageactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.299.jsonSolid Cancer N Stageactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.302.jsonHER2_IHC_Positiveactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.303.jsonHER2 Negative (geneinterpretation/Labtestvalue) SNOMEDactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.304.jsonHER2 Negative (geneinterpretation/Labtestvalue) LOINCactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.305.jsonHER2 Negative (geneinterpretation/Labtestvalue) NCIactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.307.jsonHER2 Negative (geneinterpretation/Labtestvalue)active2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.308.jsonSolid Cancer Diagnosis ICD 9active2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.309.jsonSolid Cancer Diagnosis SNOMED CTactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.310.jsonSolid Cancer Diagnosisactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.311.jsonLocalized_Solid_Cancer_Stage Group NCIMactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.313.jsonLocalized_Solid_Cancer_Stage Groupactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.314.jsonLocally_Advanced_Solid_Cancer_Stage Group NCIMactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.315.jsonLocally_Advanced_Solid_Cancer_Stage Groupactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.316.jsonMetastatic_Solid_Cancer_Stage Group NCIMactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.317.jsonMetastatic_Solid_Cancer_Stage Groupactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.318.jsonSolid Cancer T Stage LOINCactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.319.jsonSolid Cancer T Stage NCIactive2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.320.jsonSolid Cancer T Stage codesactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.321.jsonPrior_Systemic_therapy_Enhertuactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.322.jsonRET test_Solid_cancer (HGNC)active2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.323.jsonRET Positive_Solid_Cancer (geneinterpretation)active2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.324.jsonRET Negative_Solid_Cancer (geneinterpretation)active2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.325.jsonRET fusion Molecular Variants_Solid_Canceractive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.326.jsonPrior_systemic_therapy_Retevmoactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.327.jsonSelpercatinib (Retevmo) Drugactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.328.jsonBreast Cancer Diagnosis ICD9active2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.329.jsonBreast Cancer Diagnosis ICD10active2024-071
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.330.jsonBreast Cancer Diagnosisactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.331.jsonMetastatic_Breast_Cancer_Stage Groupactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.332.jsonLocally_Advanced_Breast_Cancer_Stage Groupactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.333.jsonLocalized_Breast_Cancer_Stage Groupactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.334.jsonBreast cancer M Stage (metastatic)active2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.335.jsonBreast Cancer T Stageactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.336.jsonBreast Cancer N Stageactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.337.jsonMetastatic Sites All Breast SNOMEDCTactive2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.338.jsonMetastatic Sites All Breast ICD9active2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.339.jsonMetastatic Sites All Breast ICD10active2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.340.jsonMetastatic Sites All Breast (grouped, SNOMEDCT/ICD9/ICD10)active2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.341.jsonAromatase_Inhibitor therapyactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.342.jsonCapivasertib_therapyactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.343.jsonFulvestrant_therapyactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.344.jsonPTEN_geneactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.345.jsonPTEN_geneinterpretationactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.346.jsonPIK3CA_geneactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.347.jsonPI3KCA_geneinterpretationactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.348.jsonAKTI_geneactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.349.jsonAKTI_geneinterpretationactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.350.jsonProgesterone_receptor_geneactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.351.jsonProgesterone_receptor_geneinterpretationactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.352.jsonEstrogen_receptor_geneactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.353.jsonEstrogen_receptor_geneinterpretationactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.354.jsonProgesterone_receptor_labtestactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.355.jsonProgesterone_receptor_labinterpretationactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.356.jsonEstrogen_receptor_labtestactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.357.jsonEstrogen_receptor_labinterpretationactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.358.jsonNSCLC M0 Stageactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.359.jsonHER2_IHC_test_Geneactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.360.jsonHER2_IHC_test_Labactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.361.jsonHER2_Fish_testactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.362.jsonHER2_IHC_Negativeactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.363.jsonTrodelvyactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.364.jsonChemotherapy_breast_canceractive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.365.jsonCyclin_dependent_kinaseactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.366.jsonTaxane_Trodelvyactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.367.jsonEndocrine_therapyactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.368.jsonHER2_Fish_test_Negativeactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.369.jsonHER2_IHC_Equivocalactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.370.jsonHER2 Positive_PM_resultsactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.371.jsonHER2 test_Labactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.372.jsonHER2 test_geneactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.374.jsonThyroid Cancer Diagnosisactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.375.jsonMetastatic_Thyroid_Stage Groupactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.376.jsonRET mutation_Molecular Variantsactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.377.jsonRET Gene mutationactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.378.jsonLocally_Advanced_Localized_Thyroid_Cancer_Stage Groupactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.379.jsonThyroid cancer M1_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.380.jsonThyroid_cancer_M0_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.381.jsonThyroid_cancer_T_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.382.jsonThyroid_cancer_T1_T2_T3_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.383.jsonThyroid_cancer_T4_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.384.jsonThyroid_cancer_N1b_Stage&Aboveactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.385.jsonThyroid_cancer_N_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.386.jsonMedullary_thyroid_histologyactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.387.jsonRET test_Thyroid_cancer (HGNC)active2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.388.jsonRET Positiveactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.389.jsonNSCLC N3 Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.390.jsonCRC Cancer Diagnosis ICD9active2024-081
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.391.jsonCRC Cancer Diagnosis ICD10active2024-081
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.392.jsonCRC Cancer Diagnosis ICD9/ICD10active2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.393.jsonMetastatic_CRC_Cancer_Stage Groupactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.394.jsonLocally_Advanced_Localized_CRC_Stage Groupactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.395.jsonCRC cancer M Stage (metastatic)active2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.396.jsonCRC Cancer T Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.397.jsonCRC Cancer N Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.398.jsonKRAS_geneactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.399.jsonKRAS_negativeactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.40.jsonLocoregional Breast Canceractive2023-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.400.jsonFluoropyrimidine_CRCactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.401.jsonOxaliplatinactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.402.jsonIrinotecan_based_therapyactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.403.jsonanti_VEGF_therapy_CRCactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.404.jsonanti_EGFR_therapy_CRCactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.405.jsonfruquitinibactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.406.jsonLocally_Advanced_CRC_Stage Groupactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.407.jsonLocalized_CRC_Stage Groupactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.408.jsonCRC cancer M0_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.409.jsonCRC_Cancer_T1_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.410.jsonCRC_Cancer_T2_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.411.jsonCRC_Cancer_T3_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.412.jsonCRC_Cancer_T4_Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.413.jsonCRC Cancer N1 Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.414.jsonCRC Cancer N2 Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.415.jsonCRC Cancer N2b Stageactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.416.jsonKRAS_G12C_MVactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.417.jsonKRAS_G12C_PMactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.418.jsonKRAS_positiveactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.419.jsonAdagrasibactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.42.jsonBreast Canceractive2023-101
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.420.jsoncetuximab_therapyactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.421.jsonTamoxifen_therapyactive2024-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.423.jsonEndometrial Cancer Diagnosis ICD 10active2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.425.jsonEndometrial Cancer Diagnosis ICD9CMactive2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.426.jsonEndometrial Cancer Diagnosisactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.428.jsonLocalized_Endometerial_Stage Group SNOMEDactive2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.429.jsonLocalized_Endometerial_Stage Group NCIMactive2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.431.jsonEndometrial_Sarcoma_Tumor_Histology_excactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.432.jsonEndometrial cancer M Stage (metastatic)active2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.433.jsonEndometrial_M0_Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.436.jsonPrior_therapy_Endometrialactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.437.jsonPaclitaxel_therapyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.441.jsonCarboplatin_therapyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.442.jsonDurvalumab_therapyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.444.jsonMMR_Gene_Lab_LOINCactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.447.jsonMMR_Gene_HGNCactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.449.jsonEndometrial_ Cancer N Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.451.jsonEndometrial_N0_Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.453.jsonEndometrial_N1_N2_Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.455.jsonEndometrial_T1_T3_Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.456.jsonEndometrial_T3_Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.458.jsonEndometrial_T4_Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.459.jsonEndometrial Cancer T Stageactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.46.jsonEndometrial Cancer ICD10active2023-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.460.jsonLocalized_Endometerial_Stage Group_SNOMED/NCIMactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.461.jsonMetastatic Sites All CRCactive2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.462.jsonMetastatic Sites All CRC ICD 10active2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.463.jsonMetastatic Sites All CRC ICD 9active2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.464.jsonMetastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10)active2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.465.jsonNTRK Repotrectinib Molecular Variantsactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.466.jsonNTRK_Gene_rearrangmentactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.467.jsonPrior_Systemic_therapy_Repotrectinibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.468.jsonNTRK_Positiveactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.469.jsonNTRK_test_geneactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.47.jsonSystemic treatment for endometrial canceractive2023-11
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.470.jsonTamoxifen_Trodelvyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.471.jsonToremifene_trodelvyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.472.jsonFulvestrant_Trodelvyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.473.jsonElacestrantactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.474.jsonAnastrozole_Trodelvyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.475.jsonLeuprolide_Trodelvyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.476.jsonAbemaciclibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.477.jsonPalbociclibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.478.jsonRibociclibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.479.jsonCarboplatin_Trodelvyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.48.jsonEndometrial Cancersactive2023-11
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.480.jsonCisplatin_Trodelvyactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.481.jsonCyclophosphamideactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.482.jsonMethotrexateactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.483.jsonGemcitabineactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.484.jsonCapecitabineactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.485.jsonEribulinactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.486.jsonDoxorubicinactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.487.jsonVinorelbineactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.488.jsonEpirubicinactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.489.jsonIxabepiloneactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.490.jsonOlaparibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.491.jsonTalazoparibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.492.jsonEntrectinibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.493.jsonlarotrectinibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.494.jsonAlpelisibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.495.jsonCapivasertibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.496.jsonPembrolizumabactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.497.jsonDostarlimabactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.498.jsonSelpercatinibactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.499.jsonEverolimusactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.500.jsonTrastuzumab_deruxtecanactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.501.jsonTest 23active2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.502.jsonAll Metastatic sites Endometrial SNOMEDactive2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.503.jsonAll Metastatic sites Endometrial ICD9active2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.504.jsonAll Metastatic sites Endometrial ICD10active2024-091
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.505.jsonAll Metastatic sites Endometrialactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.506.jsonCreate CRC_Cancer_T4a_Stageactive2024-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.507.jsonCreate CRC_Cancer_T4b_Stageactive2024-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.508.jsonHigh Emetogenic Risk Chemotherapyactive2025-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.510.jsonInactiveFollowupactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.53.jsonMMR Gene Testingactive2023-11
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.54.jsonMSI Highactive2023-111
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.55.jsonMSI Highactive2024-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.6.jsonOrserduactive2023-08